InsidersTradesSigma
Track the CORCEPT THERAPEUTICS INCORPORATED stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 26 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: KIMBERLY PARK. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
CORCEPT THERAPEUTICS INCORPORATED is a biopharmaceutical company focused on developing treatments for diseases related to excess cortisol. It is listed on the NASDAQ under the ticker symbol CORP.